Navigation Links
Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
Date:3/18/2013

BLUE BELL, Pa., March 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) today reported financial results for the fourth quarter and year ended December 31, 2012.

Total revenue was $1.1 million and $4.1 million for the quarter and year ended December 31, 2012, compared to $1.6 million and $9.8 million for the same periods in 2011.

Total operating expenses for the quarter and year and ended December 31, 2012, were $7.4 million and $27.6 million as compared to $7.4 million and $31.4 million for the same periods in 2011.

The net loss attributable to common stockholders for the quarter and year ended December 31, 2012, was $659,000, or $0.00 per share, and $19.7 million, or $0.14 per share, as compared with a net loss attributable to common stockholders of $5.5 million, or $0.04 per share, and $15.3 million, or $0.12 per share, for the quarter and year ended December 31, 2011.

Dr. J. Joseph Kim, Inovio's President and CEO, said, "In 2012 our DNA vaccines achieved two vital breakthroughs in human studies: best-in-class therapeutic immune responses displayed the desired killing effect against a targeted disease; broadly targeted universal vaccines generated protective immune responses against multiple unmatched strains of a pathogen. These were scientific firsts. Our current funding will carry us through additional important milestones, including efficacy data from our cervical dysplasia phase II study in Q1 2014."

Revenue The decrease in revenue for the comparable periods was primarily due to timing of work performed under the company's contract with the National Institute of Allergy and Infectious Diseases (NIAID). This contract revenue amounted to $671,000 and $2.8 million for the quarter and year ended December 31, 2012, versus $1.4 million and $7.8 million for the same periods in 2011. This NIAID contract, which provides up
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 The Open ... , Occupy Psychiatry , and leading ... care, announces a social media campaign showcasing video ... psychiatric model, which focuses on pathology and illness ... with the American Psychiatric Association,s (APA) rollout of ...
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... Spectral Analyzer (SP6800).  Sony will be exhibiting and taking ... be held at the San Diego ... , from May 20 - 22.  ... system, incorporating commercial audio-visual technologies into new and novel ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
(Date:5/19/2013)... ATS 2013, PHILADELPHIA ─ Gourmands and foodies everywhere have ... a little peppery zing to both sweet and savory ... shows purified components of the spicy root also may ... , The results of the study will be presented ... characterized by bronchoconstriction, a tightening of the bronchial tubes ...
(Date:5/19/2013)... In partnership with the medical practice online marketing ... of an SEO website for dentists. The purpose of the ... , http://www.e-dentists.com/ , A perk to the service ... they see results. Dentists can request the keywords they want ... JD Media Surge, LLC rank high for competitive keywords. Dentists ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... with quadriplegia, mutism and lower cranial nerve paralysis ... others is through vertical gaze and upper eyelid ... the June issue of Mayo Clinic Proceedings ... locked-in syndrome who also had dancing eye syndrome ...
... Rare variant may lead immune system to attack healthy ... -- A new study finds that rare gene variations ... the immune system attacks the body. These autoimmune disorders ... report that the findings could lead to better treatments ...
... ... been costly, confusing and time consuming. As a result, nearly 75% of ... all. Nearly half of all resources dedicated to new product development ... consumer packaged goods manufacturers can now launch an investigation of consumer product ...
... Boomers seeking help for drug abuse, study finds , WEDNESDAY, ... older, admissions for drug abuse treatment have nearly doubled between ... cocaine, heroin, prescription drugs, and/or marijuana abuse among men and ... 1992 to just over 12 percent by 2008, according to ...
... limited to the mouth, smokeless tobacco affects the normal ... almost every organ in the body, according to the ... Chemical Research in Toxicology . The enzymes play ... hormones estrogen and testosterone; production of cholesterol and vitamin ...
... disease receive laxatives after being treated with narcotics, despite ... These are the findings from a Nationwide Children,s Hospital ... in Pediatric Blood & Cancer . Narcotic-related ... in hospitalized children and constipation is a frequent narcotic-associated ...
Cached Medicine News:Health News:Mayo Clinic Proceedings: Gabapentin opens window of communication 2Health News:Gene Mutations Offer Clues to Autoimmune Disorders 2Health News:Marketing Research for Companies That Don't Do Marketing Research 2Health News:Marketing Research for Companies That Don't Do Marketing Research 3Health News:'Graying' of Drug Users at U.S. Treatment Centers 2Health News:Sickle cell patients should be better monitored for constipation prevention 2
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
VerdaSee Portal ID is a family of solutions that provide automated tracking and tracing of assets as they enter or leave designated areas within a healthcare facility....
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... Exit Alerting System, instantly help ... and assets (e.g. medical equipment), ... throughout your facility. With this ... quickly ensured the cost savings, ...
Medicine Products: